C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 471/04 (2006.01) A61K 31/445 (2006.01) A61P 3/10 (2006.01) C07D 221/00 (2006.01) C07D 455/06 (2006.01)
Patent
CA 2471262
The present invention relates to compounds of formula (I) wherein R1, R2, R3, R4, R5 and R6 are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prophylaxis of diseases which are associated with DPP-IV, such as diabetes, particularly non-insulin dependent diabetes mellitus, and impaired glucose tolerance.
La présente invention se rapporte à des composés de formule (I), dans laquelle R<sp>1</sp>, R<sp>2</sp>, R<sp>3</sp>, R<sp>4</sp>, R<sp>5</sp> et R<sp>6</sp> sont tels que définis dans le descriptif et les revendications, ainsi qu'à leurs sels pharmaceutiquement acceptables. Les composés sont utilisés dans le traitement et/ou la prévention de maladies associées au DPP-IV, notamment le diabète, et plus particulièrement le diabète non insulino-dépendant, et d'une altération de la tolérance au glucose.
Gobbi Luca Claudio
Luebbers Thomas
Mattei Patrizio
Narquizian Robert
Wyss Pierre Charles
F. Hoffmann-La Roche Ag
Gowling Lafleur Henderson Llp
LandOfFree
Pyrido(2,1-a)isoquinoline derivatives as dpp-iv inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrido(2,1-a)isoquinoline derivatives as dpp-iv inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrido(2,1-a)isoquinoline derivatives as dpp-iv inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1689270